Men comprise 70% of India's COVID-19 deaths and 63% of total caseload, says health ministry

The Centre also noted there is no evidence that current COVID-19 vaccines will fail to protect against the SARS-CoV-2 mutants reported from the UK or South Africa.

FP Staff December 29, 2020 18:45:04 IST
Men comprise 70% of India's COVID-19 deaths and 63% of total caseload, says health ministry

Union Health Secretary Rajesh Bhushan speaks during a media presser on COVID-19 situation in India on Tuesday. ANI

Giving a break-up on the basis of the gender and age of those infected with the novel coronavirus , Union health secretary Rajesh Bhushan on Tuesday said men and women respectively account for 63 percent and 37 percent of the total cases in the country.

"Eight percent cases have been reported below the age of 17 years, 13 percent in the 18-25 years age group, 39 percent in 26-44 years group, 26 percent in 45-60 years group and 14 percent above 60 years," Bhushan said, while addressing a press conference.

Bhushan said 70 percent of COVID deaths have been reported in men and 45 percent fatalities due to this disease have been reported in those below 60 years of age.

He also added the number of active cases has been registered at 2.7 lakhs after six months, and the cumulative positivity rate is at 6.02 percent while the positivity rate during last week was 2.25 percent.

"Five states and UTs which account for 60 percent of total active COVID-19 cases are Maharashtra, Kerala, West Bengal, Uttar Pradesh and Chhattisgarh," he said.

Meanwhile, the Centre said that COVID-19 vaccines will work against new variants of the virus and there is no evidence that current vaccines will fail to protect against the SARS-CoV-2 mutations reported from the UK or South Africa.

Principal Scientific Advisor K Vijay Raghavan said so far it has not been found that the new variant increases the severity of the disease.

"There is no evidence that current vaccines will fail to protect against COVID 19 variants reported from UK or SA. Most vaccines do target the spike protein, in which there are changes in the variants but vaccines stimulate our immune system to produce a wide range of protective antibodies," he said.

NITI Aayog member (health) Dr VK Paul said there has been a consistent decline in the number of new COVID-19 cases and deaths which is reassuring given the current scenario across the world.

"We are consistently showing a decline in the number of new COVID-19 cases, active cases, and deaths, which is very reassuring. It stands out particularly during this very period when several nations are facing a devastating situation," Paul said.

He said a majority of the population is still susceptible to the infection in the cold weather. "The UK variant has traveled to several other countries and also to India, this variant may have its own run and we have to very careful," Paul said.

With inputs from PTI

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

India records 15,144 new COVID-19 cases; national recovery rate is now 96.58%
India

India records 15,144 new COVID-19 cases; national recovery rate is now 96.58%

There are 2,08,826 active cases of coronavirus infection in the country which constitute 1.98 percent of the total caseload, the data showed

Narendra Modi launches vaccination drive against COVID-19, says campaign will ensure 'decisive victory' over pandemic
India

Narendra Modi launches vaccination drive against COVID-19, says campaign will ensure 'decisive victory' over pandemic

Modi reminded people that two doses of vaccine are very important and asked them to keep wearing masks and maintain social distancing even after receiving the jabs

As India preps for COVID-19 vaccine rollout, Centre says 'no proposal' to indemnify vaccine manufacturers
India

As India preps for COVID-19 vaccine rollout, Centre says 'no proposal' to indemnify vaccine manufacturers

Centre in response to an RTI filed said that it currently has no proposal to indemnify or exempt vaccine manufacturers from any liability in case of serious side-effects/adverse reactions due to inoculation of their vaccines.